Foundations of Lung Disease

The Foundations of Lung Disease team aims to help all kids breathe better, from infancy through to early adult life.

Our research focuses on three broad areas:

Examining childhood lung disease

The team seeks to gain a greater understanding of a variety of lung diseases including asthma, cystic fibrosis, chronic lung disease of prematurity and neuromuscular diseases. We are also interested in the impact of inflammation and infection on lung function. Research in this area involves determining the most appropriate methods to assess lung function depending on disease type and age of the child. We are also interested in the detection of sensitive biological markers to identify and prevent the progression of lung disease.

Tracking lung growth and development from infancy to early adulthood

By tracking lung health from birth through childhood, adolescence and early adulthood, the team aims to maximise opportunities to prevent the development and/or improve the management of chronic lung diseases later in life. This involves examining the impact of neonatal factors, low lung function and respiratory symptoms on long-term respiratory outcomes.

Research Translation

Central to the team’s research is expanding the evidence base for international guidelines to improve the clinical management of childhood respiratory diseases. The team fosters local, national, and international collaborations to ensure the most relevant research questions are being asked and the community are actively engaged in research activities. This helps facilitate rapid and effective implementation of research outcomes.

If you would like to stay up to date with our team projects, follow us on Facebook:

https://www.facebook.com/WalyanCentre/

Prematurity Associated Lung Disease: What does primary care need to know

Watch this webinar exploring prematurity-associated lung disease across the lifespan, with a focus on holistic care, long-term impacts, and practical strategies to support patients and families—from infancy to adulthood. Learn about risk factors, management, and the latest resources to inform your practice. Hear from experts in the field and parents with lived experience. 

Learning outcomes

Understand the lifelong impact of prematurity on the lungs.
Identify appropriate pathways and resources for management of patients with prematurity associated lung disease.
Apply new knowledge in clinical practice.
This virtual event is accredited with Royal Australian College of General Practitioners (RACGP- Activity ID 125148) for one hour of Educational Activity. This education has been approved as a Lung Learning Quality-Assured Activity. 

For a certificate of attendance please complete the feedback survey.